BioSpace News Archive

Business

Clementia Appoints Industry Veteran Pierre Legault to its Board of Directors

Mr. Legault is an accomplished leader in the biopharmaceutical industry with a proven track record.

January 31, 2018
·
4 min read
Business

Michaela Gertz Joins Immunicum as CFO

Lise-Lotte Hallbäck will leave her position as CFO of Immunicum as of today to pursue other interests.

January 31, 2018
·
2 min read
Drug Development

BeiGene Initiates Global Phase III Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Esophageal Squamous Cell Carcinoma

Tislelizumab is also being studied in global Phase 3 trials in non-small cell lung cancer and hepatocellular carcinoma and two pivotal Phase 2 trials in China in relapsed/refractory classical Hodgkin lymphoma and urothelial cancer.

January 31, 2018
·
6 min read
Pharm Country

New Phantom v2640 Ultrahigh Speed Camera Achieves Unmatched 4-Mpx Resolution

The v2640 features very high dynamic range and the lowest noise floor of any Phantom camera.

January 31, 2018
·
3 min read
Business

Alex Gu Named Senior Vice President and President of Medtronic’s Greater China Region

Gu will serve on the company’s Executive Committee and succeeds Chris Lee, who was named President of Medtronic’s Asia Pacific (APAC) Region in December. This change is effective immediately.

January 31, 2018
·
2 min read
Policy

Novelion Therapeutics Announces Sentencing of Subsidiary Aegerion Pharmaceuticals

Financial terms of the sentence align with previous company filings.

January 31, 2018
·
5 min read
Drug Development

Puma Biotechnology Announces Publication of Results from Phase II SUMMIT ‘Basket’ Trial Evaluating Neratinib in HER2 and HER3 Mutant Cancers

Puma Biotechnology announced that initial results from the company’s ongoing SUMMIT Phase II ‘basket’ clinical trial of PB272 (neratinib) in patients with tumors harboring HER2 or HER3 mutations were published in the journal Nature.

January 31, 2018
·
9 min read
Change in the Number of Shares and Votes in Immunicum

The number of shares and votes in Immunicum has, as a result of a rights issue of shares, increased with 24,999,990, from 25,958,541 to 50,958,531.

January 31, 2018
·
1 min read
Pharm Country

Advanced Biomedical Technologies Granted New Patent Strengthening its Core Technology

The company’s subsidiary Shenzhen Changhua Biomedical Engineering Company Limited is entitled for the new patent.

January 31, 2018
·
4 min read
Genetown

resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

The shares commenced trading on the NASDAQ Global Select Market on January 26, 2018 under the ticker symbol “TORC.”

January 31, 2018
·
2 min read